Evelyn is the Senior Vice President & Chief Clinical Operations Officer at IVERIC bio, Inc. and a member of their Executive Leadership Team. Prior to joining IVERIC bio (formerly Ophthotech Corporation) in 2007, Evelyn was with Eyetech Pharmaceuticals, Inc. where she held the positions of Vice President and Senior Vice President of Clinical Research and Development. While at Eyetech, Evelyn played a key role in the development and approval of Macugen® (pegaptanib sodium) for the treatment of wet age-related macular degeneration.
Evelyn has more than 30 years of management, clinical research and development experience in the biotech industry. Her career started at Hoffmann-LaRoche where she held several positions in clinical development and was responsible for the development and implementation of strategic programs for Roche’s oncology franchise. She has worked on all phases of global clinical trials in multiple therapeutic areas such as ophthalmology, bone marrow transplantation, organ transplantation, and virology.
Evelyn holds a BA degree in Biology from Hofstra University and an MBA from Manhattan College.